Please wait a minute...
Search Asian J Urol Advanced Search
Share 
Asian Journal of Urology, 2016, 3(2): 103-106    doi: 10.1016/j.ajur.2015.11.007
  本期目录 | 过刊浏览 | 高级检索 |
Prostatic sarcoma of the Ewing family in a 33-year-old male——A case report and review of the literature
Lukas Escha, Dimitri Barskia, Reinhold Bugb, Thomas Ottoa
a Department of Urology, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany;
b Department of Pathology, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany
Prostatic sarcoma of the Ewing family in a 33-year-old male——A case report and review of the literature
Lukas Escha, Dimitri Barskia, Reinhold Bugb, Thomas Ottoa
a Department of Urology, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany;
b Department of Pathology, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany
下载:  PDF (1251KB) 
输出:  BibTeX | EndNote (RIS)      
摘要 Ewing sarcoma is the second most common primary bone tumor seen in children and adolescents, typically presenting between 10 and 20 years of age. Extraosseous sarcomas of the Ewing family in adults are rare. We report a manifestation of this tumor entity in the periprostatic tissue of a 33-year-old male and discuss our treatment approach. Transrectal biopsy is a feasible and simple diagnostic tool for unclear pelvic masses. Multi-modal therapy and central registries are needed to gain knowledge of rare pelvic tumors like Ewing sarcoma.
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
Lukas Esch
Dimitri Barski
Reinhold Bug
Thomas Otto
关键词:  Ewing sarcoma  Pelvic neoplasms  Adult  Surgery  Chemotherapy  Prostate    
Abstract: Ewing sarcoma is the second most common primary bone tumor seen in children and adolescents, typically presenting between 10 and 20 years of age. Extraosseous sarcomas of the Ewing family in adults are rare. We report a manifestation of this tumor entity in the periprostatic tissue of a 33-year-old male and discuss our treatment approach. Transrectal biopsy is a feasible and simple diagnostic tool for unclear pelvic masses. Multi-modal therapy and central registries are needed to gain knowledge of rare pelvic tumors like Ewing sarcoma.
Key words:  Ewing sarcoma    Pelvic neoplasms    Adult    Surgery    Chemotherapy    Prostate
收稿日期:  2015-08-26      修回日期:  2015-11-05           出版日期:  2016-04-01      发布日期:  2016-05-13      整期出版日期:  2016-04-01
通讯作者:  Dimitri Barski    E-mail:  dbarski@lukasneuss.de
引用本文:    
Lukas Esch, Dimitri Barski, Reinhold Bug, Thomas Otto. Prostatic sarcoma of the Ewing family in a 33-year-old male——A case report and review of the literature[J]. Asian Journal of Urology, 2016, 3(2): 103-106.
Lukas Esch, Dimitri Barski, Reinhold Bug, Thomas Otto. Prostatic sarcoma of the Ewing family in a 33-year-old male——A case report and review of the literature. Asian Journal of Urology, 2016, 3(2): 103-106.
链接本文:  
http://www.ajurology.com/CN/10.1016/j.ajur.2015.11.007  或          http://www.ajurology.com/CN/Y2016/V3/I2/103
[1] Chen QR, Vansant G, Oades K, Pickering M, Wei JS, Song YK, et al. Diagnosis of the small round blue cell tumors using multiplex polymerase chain reaction. J Mol Diagn 2007;9:80-8.
[2] Rajwanshi A, Srinivas R, Upasana G. Malignant small round cell tumors. J Cytol 2008;26:1-10.
[3] Thway K. Primitive round cell neoplasms. Surg Pathol Clin 2010;4:799-818.
[4] Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, et al. The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994;331:294-9.
[5] Gu M, Antonescu CR, Guiter G, Huvos AG, Ladanyi M, Zakowski MF. Cytokeratin immunoreactivity in Ewing's sarcoma:prevalence in 50 cases confirmed by molecular diagnostic studies. Am J Surg Pathol 2000;24:410-6.
[6] Iwamoto Y. Diagnosis and treatment of Ewing's sarcoma. Jpn J Clin Oncol 2007;37:79-89.
[7] Postel-Vinay S, Véron AS, Tirode F, Pierron G, Reynaud S, Kovar H, et al. Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. Nat Genet 2012;44:323-7.
[8] Applebaum MA, Worch J, Matthay KK, Goldsby R, Neuhaus J, West DC. Clinical features and outcomes in patients with extraskeletal Ewing sarcoma. Cancer 2011;117:3027-32.
[9] Eyre R, Feltbower RG, James PW, Blakey K, Mubwandarikwa E, Forman D, et al. The epidemiology of bone cancer in 0-39 year olds in northern England, 1981-2002. BMC Cancer 2010; 10:357.
[10] Jawad MU, Cheung MC, Min ES, Schneiderbauer MM, Koniaris LG, Scully SP. Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome. Cancer 2009;115:3526-36.
[11] Esiashvili N, Goodman M, Marcus RB. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades. J Pediatr Hematol Oncol 2008;30:425-30.
[12] Eyre R, Feltbower RG, Mubwandarikwa E, Eden TOB, McNally RJQ. Epidemiology of bone tumours in children and young adults. Pediatr Blood Cancer 2009;53:941-52.
[13] Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJH, Pritchard DJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003;348:694-701.
[14] Donaldson SS, Torrey M, Link MP, Glicksman A, Gilula L, Laurie F, et al. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma:end results of POG #8346. Int J Radiat Oncol Biol Phys 1998;42:125-35.
[15] Yock TI, Krailo M, Fryer CJ, Donaldson SS, Miser JS, Chen Z, et al. Local control in pelvic Ewing sarcoma:analysis from INT-0091ea report from the Children's Oncology Group. J Clin Oncol 2006;24:3838-43.
[16] Marcus R, Hagenbeek A. The therapeutic use of rituximab in non-Hodgkin's lymphoma. Eur J Haematol Suppl 2007;78:5-14.
[17] El Weshi A, Allam A, Ajarim D, Al Dayel F, Pant R, Bazarbashi S, et al. Extraskeletal Ewing's sarcoma family of tumours in adults:analysis of 57 patients from a single institution. Clin Oncol R Coll Radiol 2010;22:374-81.
[18] Raney RB, Asmar L, Newton Jr WA, Bagwell C, Breneman JC, Crist W, et al. Ewing's sarcoma of soft tissues in childhood:a report from the intergroup Rhabdomyosarcoma Study, 1972 to 1991. J Clin Oncol 1997;15:574-82.
[19] Ellinger J, Bastian PJ, Hauser S, Biermann K, Müller SC. Primitive neuroectodermal tumor:rare, highly aggressive differential diagnosis in urologic malignancies. Urology 2006; 68:257-62.
[20] Okada Y, Kamata S, Akashi T, Kurata M, Nakamura T, Kihara K. Primitive neuroectodermal tumor/Ewing's sarcoma of the urinary bladder:a case report and its molecular diagnosis. Int J Clin Oncol 2011;16:435-8.
[21] Zhang DW, Jin M, Zhou CJ, Song HC, Ma XL.[Primitive neuroectodermal tumor/Ewing's sarcoma of the penis in children:a case report and review of the literature]. Zhonghua Nan Ke Xue 2012;18:1115-8[Article in Chinese].
[22] Tsang YP, Lang BH, Tam SC, Wong KP. Primitive neuroectodermal adrenal gland tumour. Hong Kong Med J 2014;20:444-6.
[23] Colecchia M, Dagrada GP, Poliani PL, Messina A, Pilotti S. Primary primitive peripheral neuroectodermal tumor of the prostate. Immunophenotypic and molecular study of a case. Arch Pathol 2003;127:e190-3.
[24] Peyromaure M, Vieillefond A, Boucher E, de Pinieux G, Beuzeboc P, Debré B, et al. Primitive neuroectodermal tumor of the prostate. J Urol 2003;170:182-3.
[25] Thete N, Rastogi D, Arya S, Singh A, Rao P, Chandge A, et al. Primitive neuroectodermal tumour of the prostate gland:ultrasound and MRI findings. Br J Radiol 2007;80:e180-3.
[26] Kumar V, Khurana N, Rathi AK, Malhotra A, Sharma K, Abhishek A, et al. Primitive neuroectodermal tumor of prostate. Indian J Pathol Microbiol 2008;51:386-8.
[27] Funahashi Y, Yoshino Y, Hattori R. Ewing's sarcoma/primitive neuroectodermal tumor of the prostate. Int J Urol 2009;16:769.
[28] Mohsin R, Hashmi A, Mubarak M, Sultan G, Shehzad A, Qayum A, et al. Primitive neuroectodermal tumor/Ewing's sarcoma in adult uro-oncology:a case series from a developing country. Urol Ann 2011;3:103-7.
[29] Al Haddabi I, Al Bahri M, Burney I. Cytokeratin-positive primitive neuroectodermal tumor of the prostate:case report and review of literature. Indian J Pathol Microbiol 2012;55:569-71.
[30] Wu T, Jin T, Luo D, Chen L, Li X. Ewing's sarcoma/primitive neuroectodermal tumour of the prostate a case report and literature review. Can Urol Assoc J 2013;7:458-9.
[31] Shibuya T, Mori K, Sumino Y, Sato F, Mimata H. Rapidly progressive primitive neuroectodermal tumor of the prostate:a case report and review of the literature. Oncol Lett 2015;9:634-6.
[1] Per-Anders Abrahamsson. Intermittent androgen deprivation therapy in patients with prostate cancer:Connecting the dots[J]. Asian Journal of Urology, 2017, 4(4): 208-222.
[2] Han Jie Lee, Alvin Lee, Hong Hong Huang, Palaniappan Sundaram, Keong Tatt Foo. Patients with small prostates and low-grade intravesical prostatic protrusion——A urodynamic evaluation[J]. Asian Journal of Urology, 2017, 4(4): 247-252.
[3] Johan Braeckman, Louis Denis. Management of BPH then 2000 and now 2016-From BPH to BPO[J]. Asian Journal of Urology, 2017, 4(3): 138-147.
[4] Jonathan Shunming Teo, Yee Mun Lee, Henry Sun Sien Ho. An update on transurethral surgery for benign prostatic obstruction[J]. Asian Journal of Urology, 2017, 4(3): 195-198.
[5] Dingwei Ye, Yiran Huang, Fangjian Zhou, Keji Xie, Vsevolod Matveev, Changling Li, Boris Alexeev, Ye Tian, Mingxing Qiu, Hanzhong Li, Tie Zhou, Peter De Porre, Margaret Yu, Vahid Naini, Hongchuan Liang, Zhuli Wu, Yinghao Sun. A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapynaïve patients with mCRPC in China, Malaysia, Thailand and Russia[J]. Asian Journal of Urology, 2017, 4(2): 75-85.
[6] Kai Zhang, Chris H. Bangma, Monique J. Roobol. Prostate cancer screening in Europe and Asia[J]. Asian Journal of Urology, 2017, 4(2): 86-95.
[7] Yoshiyasu Amiya, Yasutaka Yamada, Masahiro Sugiura, Makoto Sasaki, Takayuki Shima, Noriyuki Suzuki, Hiroomi Nakatsu, Shino Murakami, Jun Shimazaki. Outcomes of patients older than 75 years with non-metastatic prostate cancer[J]. Asian Journal of Urology, 2017, 4(2): 102-106.
[8] Amit Sharma, Mukund Andankar, Hemant Pathak. A rare presentation of cystic nephroma in a young adult[J]. Asian Journal of Urology, 2017, 4(2): 128-130.
[9] Geoffrey S. Gaunay, Vinay Patel, Paras Shah, Daniel Moreira, Ardeshir R. Rastinehad, Eran Ben-Levi, Robert Villani, Manish A. Vira. Multi-parametric MRI of the prostate: Factors predicting extracapsular extension at the time of radical prostatectomy[J]. Asian Journal of Urology, 2017, 4(1): 31-36.
[10] Matthew E. Pollard, Alan J. Moskowitz, Michael A. Diefenbach, Simon J. Hall. Cost-effectiveness analysis of treatments for metastatic castration resistant prostate cancer[J]. Asian Journal of Urology, 2017, 4(1): 37-43.
[11] Adam S. Howe, Moneer K. Hanna. Management of 220 adolescents and adults with complications of hypospadias repair during childhood[J]. Asian Journal of Urology, 2017, 4(1): 14-17.
[12] Geoffrey Gaunay, Vinay Patel, Paras Shah, Daniel Moreira, Simon J. Hall, Manish A. Vira, Michael Schwartz, Jessica Kreshover, Eran Ben-Levi, Robert Villani, Ardeshir Rastinehad, Lee Richstone. Role of multi-parametric MRI of the prostate for screening and staging: Experience with over 1500 cases[J]. Asian Journal of Urology, 2017, 4(1): 68-74.
[13] Jun Luo. Non-invasive actionable biomarkers for metastatic prostate cancer[J]. Asian Journal of Urology, 2016, 3(4): 170-176.
[14] Eun-Jin Yun, U-Ging Lo, Jer-Tsong Hsieh. The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges[J]. Asian Journal of Urology, 2016, 3(4): 203-210.
[15] Dong Lin, Xinya Wang, Stephen Yiu Chuen Choi, Xinpei Ci, Xin Dong, Yuzhuo Wang. Immune phenotypes of prostate cancer cells: Evidence of epithelial immune cell-like transition?[J]. Asian Journal of Urology, 2016, 3(4): 195-202.
[1] Zhixiang Wang, Bing Liu, Xiaofeng Gao, Yi Bao, Yang Wang, Huamao Ye, Yinghao Sun, Linhui Wang. Laparoscopic ureterolysis with simultaneous ureteroscopy and percutaneous nephroscopy for treating complex ureteral obstruction after failed endoscopic intervention: A technical report[J]. Asian Journal of Urology, 2015, 2(4): 238 -243 .
[2] Louis R. Kavoussi. News from leading international academic urology departments[J]. Asian Journal of Urology, 2017, 4(1): 1 -2 .
[3] Rikiya Taoka, Yoshiyuki Kakehi. The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 158 -163 .
[4] Cheuk Fan Shum, Weida Lau, Chang Peng Colin Teo. Medical therapy for clinical benign prostatic hyperplasia:a1 Antagonists, 5a reductase inhibitors and their combination[J]. Asian Journal of Urology, 2017, 4(3): 185 -190 .
[5] Foo Keong Tatt. Current consensus and controversies on male LUTS/BPH (part two)[J]. Asian Journal of Urology, 2018, 5(1): 8 -9 .
[6] Rishi R. Sekar, Claire M. De La Calle, Dattatraya Patil, Sarah A. Holzman, Yoram Baum, Umer Sheikh, Jonathan H. Huang, Adeboye O. Osunkoya, Brian P. Pollack, Haydn T. Kissick, Kenneth Ogan, Viraj A. Master. Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival[J]. Asian Journal of Urology, 2016, 3(2): 75 -81 .
[7] Ryan Yu, Jefferson Terry, Mutaz Alnassar, Jorge Demaria. Pediatric fibrous pseudotumor of the tunica vaginalis testis[J]. Asian Journal of Urology, 2016, 3(2): 99 -102 .
[8] Aso Omer Rashid, Saman Salih Fakhulddin. Risk factors for fever and sepsis after percutaneous nephrolithotomy[J]. Asian Journal of Urology, 2016, 3(2): 82 -87 .
[9] Christopher Hartman, Nikhil Gupta, David Leavitt, David Hoenig, Zeph Okeke, Arthur Smith. Advances in percutaneous stone surgery[J]. Asian Journal of Urology, 2015, 2(1): 26 -32 .
[10] Aldamanhori Reem,I.Osman Nadir,R.Chapple Christopher. Underactive bladder: Pathophysiology and clinical significance[J]. Asian Journal of Urology, 2018, 5(1): 17 -21 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed